Biosimilars 2021 Year in Review
Fish & Richardson Trademark & Copyright Thoughts
JANUARY 11, 2022
Samsung Bioepis / Biogen). Samsung Bioepis). Samsung Bioepis). Ontruzant ® (Samsung Bioepis/ Merck). Renflexis ® (Samsung Bioepis/Merck). December 17, 2021. No earlier than 2023 per settlement. Rezvoglar ™. Eli Lilly). insulin glargine-aglr. December 17, 2021. Lucentis ®.
Let's personalize your content